COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen
21/02/2019
First commercial program under Bavarian Nordic and Janssen Vaccines & Prevention B.V. collaboration advancing into clinical trials A therapeutic vaccine may represent a novel approach for early treatment and [...]
Melinta Therapeutics Announces One-for-Five Reverse Stock Split
21/02/2019
NEW HAVEN, Conn., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]
SuperSonic Imagine will present its Aixplorer® MACH 30 ultrasound system at the 25th European Congress of Radiology (ECR 2019)
21/02/2019
in Vienna, Austria, from 27 February to 3 March 2019 AIX-EN-PROVENCE, France, Feb. 21, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814, PEA-PME eligible), a company specialising in ultrasound [...]
SuperSonic Imagine présentera son échographe Aixplorer® MACH 30 lors de la 25ème édition du Congrès Européen de Radiologie (ECR) 2019
21/02/2019
à Vienne en Autriche du 27 février au 3 mars 2019 AIX-EN-PROVENCE, France, 21 févr. 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814, éligible PEA-PME), société spécialisée dans l’imagerie [...]
VitalHub Announces Intention to Enter the Patient Flow Market Through Acquisition Strategy
21/02/2019
TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce that it has imminent plans to enter the rapidly growing global patient flow market through a [...]
iCAD to Showcase ProFound AI™ Solution for Digital Breast Tomosynthesis at ECR 2019
21/02/2019
Currently pending CE Mark, ProFound AI technology for 2D mammography will also be previewed NASHUA, N.H., Feb. 21, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing [...]
AroCell AB (publ) Year-End Report 2018
21/02/2019
Word from the CEO ”2018 has been an exciting year for AroCell with several major events. In April, AroCell signed a global non-exclusive license agreement with F. Hoffmann-La Roche Ltd (Roche). Roche is the market [...]
Ossur Hf : Final agenda and proposals for the Annual General Meeting 7 March 2019
21/02/2019
Announcement no. 12/2019 21 February 2019 Final agenda and proposals Enclosed is the final agenda and proposals for Össur's Annual General Meeting to be held on Thursday 7 March 2019. The meeting will be held at Össur's [...]
Saniona publishes its year-end report for 2019
21/02/2019
PRESS RELEASE February 21, 2019 Financial highlights Jan – Dec 2018 (Jan - Dec 2017) Net revenues were SEK 54.9 M (20.7 M) EBIT was SEK -54.2 M (-57.2 M) Net profit/loss was SEK -41.1 M (-49.2) Earnings per share were [...]
VALNEVA Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019
21/02/2019
Valneva Reports Strong 2018 Results, Expects Further Growth and Major Pipeline Progression in 2019 Major R&D milestones achieved in 2018, double-digit product sales revenue growth delivered; Lyme and chikungunya [...]
VALNEVA publie de très bons résultats 2018, prévoit une poursuite de la croissance et des avancées R&D importantes en 2019
21/02/2019
Valneva publie de très bons résultats 2018, prévoit une poursuite de la croissance et des avancées R&D importantes en 2019 Avancées R&D majeures et croissance à deux chiffres du chiffre d'affaires des ventes de [...]
Biocartis Group NV: BIOCARTIS TO HOST WEBCAST FOR ANNOUNCEMENT 2018 FINANCIAL RESULTS ON 28 FEBRUARY 2019
21/02/2019
PRESS RELEASE : REGULATED INFORMATION 21 February 2019, 07:00 CET BioCARTIS to Host Webcast FOR ANNOUNCEMENT 2018 FINANCIAL Results on 28 FEBRUARY 2019 Mechelen, Belgium, 21 February 2019 - Biocartis Group NV (the ' [...]
HealthEquity to Present at Investor Conferences
20/02/2019
DRAPER, Utah, Feb. 20, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the largest independent HSA custodian, today announced that it plans to participate at the following upcoming investor conferences: BTIG [...]
Akorn Comments on Fresenius’ Proposed Amended Claims
20/02/2019
LAKE FOREST, Ill., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX) today announced that it strongly contests Fresenius’ proposed amended claims filed earlier today. Akorn believes these claims are meritless [...]
Mesoblast Reports Financial Results and Operational Highlights for the First Half Ended December 31, 2018
20/02/2019
Strong cash reserves as Company prepares for potential US launch of remestemcel-L MELBOURNE, Australia and NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today reported its [...]
Hoth Therapeutics Inc. Announces Closing of Initial Public Offering
20/02/2019
NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Hoth Therapeutics Inc. (NASDAQ: HOTH), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as [...]
Immunomedics Announces Publication of Triple-Negative Breast Cancer Data With Sacituzumab Govitecan in the New England Journal of Medicine
20/02/2019
Publication Highlights Safety and Efficacy Profile of Sacituzumab Govitecan Addressing High Unmet Need in Metastatic Triple-Negative Breast Cancer MORRIS PLAINS, N.J., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc [...]
MannKind Presents New Scientific Data at 12th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2019)
20/02/2019
WESTLAKE VILLAGE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced additional positive Afrezza clinical data to be presented in an oral presentation on Thursday, February 21, [...]
PLx Pharma Inc. Announces Completion of $15 Million Convertible Preferred Stock Financing
20/02/2019
HOUSTON, Feb. 20, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“ PLx ” or the “ Company ”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Vazalore™ [...]

Pages